Autocrine CCL2 Signaling Drives Medulloblastoma Growth and Unveils Eight Prognostic Biomarkers
Ablating autocrine CCL2 signaling in medulloblastoma cells disrupts multiple oncogenic pathways and reveals an eight-gene expression signature strongly tied to ...










